Market Closed -
Nyse
Other stock markets
|
5-day change | 1st Jan Change | ||
45.68 USD | +0.04% | -0.35% | +2.03% |
Sep. 18 | QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform | CI |
Sep. 13 | Qiagen, Bio-Manguinhos/Fiocruz Launch Malaria Detection Test in Brazil | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.53B | 1.87B | 2.25B | 2.14B | 1.97B | |||||
Total Revenues | 1.53B | 1.87B | 2.25B | 2.14B | 1.97B | |||||
Cost of Goods Sold, Total | 450M | 574M | 734M | 696M | 667M | |||||
Gross Profit | 1.08B | 1.3B | 1.52B | 1.45B | 1.3B | |||||
Selling General & Admin Expenses, Total | 504M | 525M | 584M | 604M | 579M | |||||
Stock-Based Compensation (IS) | 25.94M | - | - | - | - | |||||
R&D Expenses | 157M | 149M | 190M | 190M | 199M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 101M | 83.98M | 85.66M | 75.01M | 74.96M | |||||
Other Operating Expenses | 19.37M | - | - | - | - | |||||
Other Operating Expenses, Total | 808M | 758M | 860M | 869M | 853M | |||||
Operating Income | 268M | 537M | 658M | 577M | 445M | |||||
Interest Expense, Total | -74.18M | -71.32M | -54.48M | -58.36M | -53.41M | |||||
Interest And Investment Income | 22.11M | 10.03M | 9.56M | 40.26M | 78.99M | |||||
Net Interest Expenses | -52.07M | -61.28M | -44.92M | -18.1M | 25.58M | |||||
Income (Loss) On Equity Invest. | 2.1M | 5M | 12M | 3.8M | 4.16M | |||||
Currency Exchange Gains (Loss) | -5.7M | -4.1M | -9M | 2.7M | -5.8M | |||||
Other Non Operating Income (Expenses) | -69K | 526K | 871K | -7.26M | 84K | |||||
EBT, Excl. Unusual Items | 213M | 478M | 617M | 558M | 469M | |||||
Restructuring Charges | -301M | -4.29M | -2.36M | -900K | - | |||||
Merger & Related Restructuring Charges | - | -127M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 3M | 123M | 36.8M | - | -4.16M | |||||
Gain (Loss) On Sale Of Assets | - | 1.6M | - | - | - | |||||
Asset Writedown | -1.26M | - | - | -12.97M | - | |||||
Legal Settlements | - | - | -4.7M | - | - | |||||
Other Unusual Items | 8.5M | -31.15M | -20.7M | -31.3M | -35.31M | |||||
EBT, Incl. Unusual Items | -77.78M | 439M | 626M | 513M | 430M | |||||
Income Tax Expense | -36.32M | 80.28M | 113M | 89.39M | 88.51M | |||||
Earnings From Continuing Operations | -41.46M | 359M | 513M | 423M | 341M | |||||
Net Income to Company | -41.46M | 359M | 513M | 423M | 341M | |||||
Minority Interest | - | - | - | - | - | |||||
Net Income - (IS) | -41.46M | 359M | 513M | 423M | 341M | |||||
Net Income to Common Incl Extra Items | -41.46M | 359M | 513M | 423M | 341M | |||||
Net Income to Common Excl. Extra Items | -41.46M | 359M | 513M | 423M | 341M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.19 | 1.62 | 2.32 | 1.92 | 1.54 | |||||
Basic EPS - Continuing Operations | -0.19 | 1.62 | 2.32 | 1.92 | 1.54 | |||||
Basic Weighted Average Shares Outstanding | 220M | 222M | 221M | 221M | 221M | |||||
Net EPS - Diluted | -0.19 | 1.58 | 2.28 | 1.9 | 1.53 | |||||
Diluted EPS - Continuing Operations | -0.19 | 1.58 | 2.28 | 1.9 | 1.53 | |||||
Diluted Weighted Average Shares Outstanding | 220M | 227M | 225M | 223M | 224M | |||||
Normalized Basic EPS | 0.6 | 1.35 | 1.74 | 1.58 | 1.33 | |||||
Normalized Diluted EPS | 0.6 | 1.31 | 1.71 | 1.56 | 1.31 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 482M | 735M | 864M | 774M | 639M | |||||
EBITA | 391M | 641M | 762M | 670M | 539M | |||||
EBIT | 268M | 537M | 658M | 577M | 445M | |||||
EBITDAR | 506M | 760M | 891M | 801M | 667M | |||||
Effective Tax Rate - (Ratio) | 46.7 | 18.27 | 18.09 | 17.44 | 20.59 | |||||
Current Domestic Taxes | 5.67M | 270K | 1.71M | 9.67M | 11.39M | |||||
Current Foreign Taxes | 13.37M | 86.72M | 117M | 89.32M | 66.38M | |||||
Total Current Taxes | 19.04M | 86.99M | 119M | 98.99M | 77.78M | |||||
Deferred Domestic Taxes | 4.18M | -6.92M | -1.78M | -683K | -5.54M | |||||
Deferred Foreign Taxes | -59.54M | 215K | -3.51M | -8.92M | 16.27M | |||||
Total Deferred Taxes | -55.36M | -6.71M | -5.29M | -9.6M | 10.73M | |||||
Normalized Net Income | 133M | 299M | 385M | 349M | 293M | |||||
Interest Capitalized | - | - | - | - | 1.2M | |||||
Interest on Long-Term Debt | 68M | 63.5M | 50.7M | 55.1M | 52.4M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 8.1M | 9.5M | 13.5M | 15.8M | 11.5M | |||||
Selling and Marketing Expenses | 392M | 414M | 456M | 474M | 460M | |||||
General and Administrative Expenses | 112M | 112M | 128M | 130M | 119M | |||||
Research And Development Expense From Footnotes | 157M | 149M | 190M | 190M | 199M | |||||
Net Rental Expense, Total | 24.38M | 25M | 27.2M | 27M | 28.6M | |||||
Imputed Operating Lease Interest Expense | 7.3M | 7.47M | 5.8M | 6.25M | 6.75M | |||||
Imputed Operating Lease Depreciation | 17.08M | 17.53M | 21.4M | 20.75M | 21.85M | |||||
Maintenance & Repair Expenses, Total | 10.7M | 13.8M | 16.2M | 16.8M | 19.3M | |||||
Stock-Based Comp., COGS (Total) | 2.49M | 2.9M | 40K | 2.58M | 3.3M | |||||
Stock-Based Comp., R&D Exp. (Total) | 5.81M | 7.01M | 4.91M | 6.5M | 7.48M | |||||
Stock-Based Comp., S&M Exp. (Total) | 7.95M | 15.89M | 13.63M | 16.08M | 14.5M | |||||
Stock-Based Comp., G&A Exp. (Total) | 23.71M | 15.14M | 19.81M | 24.35M | 21.82M | |||||
Stock-Based Comp., Other (Total) | 25.94M | - | - | - | - | |||||
Total Stock-Based Compensation | 65.89M | 40.94M | 38.39M | 49.51M | 47.1M |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 624M | 598M | 881M | 731M | 668M | |||||
Short Term Investments | 130M | 117M | 185M | 688M | 390M | |||||
Total Cash And Short Term Investments | 753M | 715M | 1.07B | 1.42B | 1.06B | |||||
Accounts Receivable, Total | 385M | 389M | 376M | 334M | 397M | |||||
Other Receivables | 79.14M | 92.24M | 64.32M | 72.39M | 98.82M | |||||
Notes Receivable | - | 17.09M | 6.25M | 29K | - | |||||
Total Receivables | 464M | 498M | 447M | 406M | 496M | |||||
Inventory | 171M | 291M | 328M | 358M | 398M | |||||
Prepaid Expenses | 45.41M | 61.16M | 60.63M | 50.96M | 44.85M | |||||
Deferred Tax Assets Current | - | - | - | - | - | |||||
Restricted Cash | 8.43M | 56.1M | 11.2M | 21.08M | 87.67M | |||||
Other Current Assets, Total | 128M | 45.26M | 198M | 140M | 63.14M | |||||
Total Current Assets | 1.57B | 1.67B | 2.11B | 2.39B | 2.15B | |||||
Gross Property Plant And Equipment | 1.21B | 1.29B | 1.37B | 1.26B | 1.39B | |||||
Accumulated Depreciation | -699M | -630M | -632M | -503M | -517M | |||||
Net Property Plant And Equipment | 513M | 662M | 739M | 758M | 870M | |||||
Long-term Investments | 87.05M | 24.48M | 33.48M | 39.16M | 23.68M | |||||
Goodwill | 2.14B | 2.36B | 2.35B | 2.35B | 2.48B | |||||
Other Intangibles, Total | 632M | 726M | 627M | 545M | 527M | |||||
Loans Receivable Long-Term | 16.83M | 10.79M | - | - | - | |||||
Deferred Tax Assets Long-Term | 56.54M | 54.88M | 72.9M | 56.3M | 38.6M | |||||
Deferred Charges Long-Term | - | - | - | - | - | |||||
Other Long-Term Assets, Total | 219M | 403M | 214M | 143M | 32.52M | |||||
Total Assets | 5.24B | 5.91B | 6.15B | 6.29B | 6.12B | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 84.77M | 118M | 101M | 98.73M | 84.16M | |||||
Accrued Expenses, Total | 171M | 162M | 172M | 181M | 170M | |||||
Current Portion of Long-Term Debt | 285M | 42.54M | 848M | 390M | 588M | |||||
Current Portion of Leases | 18.74M | 23.45M | 22.05M | 22.22M | 22.27M | |||||
Current Income Taxes Payable | 33.86M | 57.26M | 27.67M | 13.98M | 12.48M | |||||
Unearned Revenue Current, Total | 48.52M | 57.07M | 63.37M | 69M | 66.43M | |||||
Deferred Tax Liability Current | - | - | - | - | - | |||||
Other Current Liabilities | 309M | 154M | 283M | 200M | 136M | |||||
Total Current Liabilities | 951M | 615M | 1.52B | 975M | 1.08B | |||||
Long-Term Debt | 1.43B | 1.9B | 1.09B | 1.51B | 1.02B | |||||
Long-Term Leases | 39.63M | 85.58M | 76.53M | 71.41M | 79.06M | |||||
Unearned Revenue Non Current | 7.7M | 11.8M | 11.3M | 15.2M | 15.7M | |||||
Pension & Other Post Retirement Benefits | 8.2M | 9.3M | 9.3M | 7.2M | - | |||||
Deferred Tax Liability Non Current | 23.44M | 39.22M | 37.59M | 17.5M | - | |||||
Other Non Current Liabilities | 242M | 456M | 303M | 226M | 113M | |||||
Total Liabilities | 2.7B | 3.11B | 3.05B | 2.82B | 2.31B | |||||
Common Stock, Total | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | |||||
Additional Paid In Capital | 1.78B | 1.83B | 1.82B | 1.87B | 1.92B | |||||
Retained Earnings | 1.18B | 1.32B | 1.79B | 2.16B | 2.46B | |||||
Treasury Stock | -112M | -118M | -190M | -160M | -133M | |||||
Comprehensive Income and Other | -310M | -244M | -327M | -404M | -434M | |||||
Total Common Equity | 2.54B | 2.8B | 3.1B | 3.47B | 3.81B | |||||
Minority Interest | - | - | - | - | - | |||||
Total Equity | 2.54B | 2.8B | 3.1B | 3.47B | 3.81B | |||||
Total Liabilities And Equity | 5.24B | 5.91B | 6.15B | 6.29B | 6.12B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 221M | 221M | 220M | 221M | 221M | |||||
ECS Total Common Shares Outstanding | 221M | 221M | 220M | 221M | 221M | |||||
Book Value / Share | 11.48 | 12.65 | 14.06 | 15.69 | 17.2 | |||||
Tangible Book Value | -236M | -292M | 118M | 569M | 805M | |||||
Tangible Book Value Per Share | -1.07 | -1.32 | 0.54 | 2.58 | 3.64 | |||||
Total Debt | 1.77B | 2.05B | 2.04B | 1.99B | 1.71B | |||||
Net Debt | 1.02B | 1.33B | 976M | 574M | 652M | |||||
Debt Equivalent Oper. Leases | 195M | 200M | 218M | 216M | 229M | |||||
Minority Interest, Total (Incl. Fin. Div) | - | - | - | - | - | |||||
Equity Method Investments, Total | 11.63M | 15M | 29.54M | 26.9M | 20.6M | |||||
Account Code - Inventory Valuation | 3 | 3 | 3 | 3 | 3 | |||||
Inventories - Raw Materials, Total | 26.08M | 65.45M | 94.75M | 97.61M | 91.2M | |||||
Inventories - Work In Process, Total | 45.73M | 74.4M | 67.68M | 85.49M | 94.74M | |||||
Inventories - Finished Goods, Total | 98.9M | 151M | 165M | 175M | 212M | |||||
Land - (BS) | 17.68M | 18.9M | 26.73M | 25.48M | 26.24M | |||||
Buildings, Total | 341M | 363M | 372M | 363M | 383M | |||||
Machinery, Total | 395M | 431M | 450M | 384M | 401M | |||||
Full Time Employees | 5.1K | 5.32K | 5.59K | 5.31K | 5.19K | |||||
Part Time Employees | - | 168 | 151 | 290 | 340 | |||||
Accumulated Allowance for Doubtful Accounts (Supple) | 12.12M | 27.05M | 23.12M | 22.88M | 17.3M |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | -41.46M | 359M | 513M | 423M | 341M | |||||
Depreciation & Amortization - CF | 90.6M | 94.38M | 101M | 104M | 99.88M | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 123M | 103M | 104M | 93.71M | 93.76M | |||||
Depreciation & Amortization, Total | 213M | 198M | 206M | 198M | 194M | |||||
Amortization of Deferred Charges, Total - (CF) | 59.06M | 49.72M | 41.49M | 44.5M | 41.86M | |||||
(Gain) Loss on Sale of Investments - (CF) | 2.87M | -124M | -29.54M | 6.23M | - | |||||
Asset Writedown & Restructuring Costs | 145M | 1.43M | - | 12.97M | 4.16M | |||||
Stock-Based Compensation (CF) | 65.89M | 40.94M | 38.39M | 49.51M | 47.1M | |||||
Tax Benefit from Stock Options | - | - | - | - | - | |||||
Other Operating Activities, Total | -69.19M | 4.99M | 334K | 13.13M | 18.35M | |||||
Change In Accounts Receivable | -39.58M | -14.71M | -7.4M | 15.45M | -55.12M | |||||
Change In Inventories | -30.03M | -108M | -81.8M | -61.95M | -44.79M | |||||
Change In Accounts Payable | 9.25M | 8.44M | -5.98M | -1.76M | -22.42M | |||||
Change In Income Taxes | -6.78M | 4.68M | -12.83M | -21.89M | -7.46M | |||||
Change in Other Net Operating Assets | 22.81M | 36.89M | -22M | 38.27M | -57.18M | |||||
Cash from Operations | 331M | 458M | 639M | 715M | 459M | |||||
Capital Expenditure | -118M | -133M | -190M | -129M | -150M | |||||
Sale of Property, Plant, and Equipment | - | - | - | - | - | |||||
Cash Acquisitions | -68.06M | -240M | - | -63.65M | -150M | |||||
Divestitures | 1M | 1.84M | - | - | - | |||||
Sale (Purchase) of Intangible assets | -157M | -171M | -16.63M | -20.11M | -13.09M | |||||
Investment in Marketable and Equity Securities, Total | 96.97M | 157M | -40.74M | -504M | 291M | |||||
Other Investing Activities, Total | 22.7M | -58.41M | 44.84M | -9.77M | -66.55M | |||||
Cash from Investing | -222M | -443M | -202M | -727M | -87.66M | |||||
Short Term Debt Issued, Total | - | 59.34M | - | - | - | |||||
Long-Term Debt Issued, Total | - | 498M | - | 371M | - | |||||
Total Debt Issued | - | 557M | - | 371M | - | |||||
Short Term Debt Repaid, Total | - | -58.7M | - | - | - | |||||
Long-Term Debt Repaid, Total | -640M | -534M | -41.34M | -480M | -437M | |||||
Total Debt Repaid | -640M | -593M | -41.34M | -480M | -437M | |||||
Issuance of Common Stock | 137M | 7.66M | 7.92M | 121K | 36.92M | |||||
Repurchase of Common Stock | -124M | -77.84M | -124M | -25.36M | -17.68M | |||||
Other Financing Activities, Total | -11.28M | 55.6M | 6.62M | 7.98M | -16.32M | |||||
Cash from Financing | -639M | -50.13M | -150M | -126M | -434M | |||||
Foreign Exchange Rate Adjustments | 826K | 4.2M | -3.68M | -12.54M | -558K | |||||
Net Change in Cash | -530M | -31.41M | 283M | -150M | -62.58M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 29.72M | 25.35M | 21.59M | 23.21M | 20.35M | |||||
Cash Income Tax Paid (Refund) | 41.47M | 42.57M | 102M | 98.56M | 82.41M | |||||
Levered Free Cash Flow | 308M | 42.04M | 463M | 448M | 157M | |||||
Unlevered Free Cash Flow | 313M | 44.3M | 464M | 451M | 160M | |||||
Change In Net Working Capital | -123M | 233M | -6.48M | 18.4M | 208M | |||||
Net Debt Issued / Repaid | -640M | -35.55M | -41.34M | -109M | -437M |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets |